Sign inJoin waitlistJoin the waitlist

Polly Niravath

Physician · Houston Methodist Hospital

Credentials: · · · ·

History

Houston Methodist Hospital
2026–Present

Baylor College of Medicine
2009–2011
Internal Medicine
Baylor College of Medicine
2005–2008
University of California, Irvine School of Medicine
2001–2005

Research

TBCRC 022: A Phase II Trial of Neratinib and Capecitabine for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases
Journal of Clinical Oncology · 2019 · 299 citations
Effect of a Scalp Cooling Device on Alopecia in Women Undergoing Chemotherapy for Breast Cancer: The SCALP Randomized Clinical Trial
JAMA · 2017 · 174 citations
Aromatase inhibitor-induced arthralgia: a review
Review · Annals of Oncology · 2013 · Sole author · 167 citations

Jen-Yun Chang
11 papers · 5 as a resident
Mothaffar Rimawi
11 papers
Tejal Patel
8 papers
MS
Mary Schwartz
6 papers
Bin Teh
5 papers
JN
Julie Nangia
5 papers
Kent Osborne
5 papers
TS
Tania Small
5 papers
Brian Butler
4 papers
JD
Jorge Darcourt
4 papers
Kai Sun
4 papers · 1 as a fellow
Kartik Anand
4 papers · 1 as a fellow

Clinical trials

Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC)
Principal investigator · Recruiting · Phase 2
The Methodist Hospital Research Institute
2023–2028
Fulvestrant+Abemaciclib With Run-In of Fulvestrant in Er-Positive, Her2-Negative Metastatic Breast Cancer
Principal investigator · Recruiting · Phase 2
The Methodist Hospital Research Institute
2021–2027
Durvalumab With Trastuzumab and Pertuzumab in HER2-Enriched Breast Cancer
Principal investigator · Active not recruiting · Phase 2
The Methodist Hospital Research Institute
2020–2028
Olaparib in Combination With Vorinostat in Patients With Relapsed/Refractory and/or Metastatic Breast Cancer
Principal investigator · Active not recruiting · Phase 1
The Methodist Hospital Research Institute
2019–2026